natgillin/translations-raw huggingface dataset:
The comments from the applicant received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006 have been considered when setting the measures provided for in this Regulation.
Uredbo (EU) št. 432/2012 bi bilo zato treba ustrezno spremeniti.
Regulation (EU) No 432/2012 should therefore be amended accordingly.
Opravljeno je bilo posvetovanje z državami članicami –
The Member States have been consulted,
SPREJELA NASLEDNJO UREDBO:
Article 1
Zdravstvena trditev iz Priloge k tej uredbi se uvrsti na seznam dovoljenih trditev Unije v skladu s členom 13(3) Uredbe (ES) št. 1924/2006.
The health claim set out in the Annex to this Regulation shall be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Uporaba zdravstvene trditve iz prvega odstavka se omeji na vložnika za obdobje pet let od datuma začetka veljavnosti te uredbe.
The use of the health claim referred to in the first paragraph shall be restricted to the applicant for a period of five years from the date of entry into force of this Regulation.
Po poteku navedenega obdobja lahko navedeno zdravstveno trditev v skladu s pogoji, ki zanjo veljajo, uporabljajo vsi nosilci živilske dejavnosti.
After the expiry of that period, that health claim may be used, in conformity with the conditions applying to it, by any food business operator.
Člen 2
Article 2
Uporaba znanstvenih podatkov in drugih informacij iz vloge, za katere je vložnik zahteval zaščito podatkov in brez predložitve katerih zdravstvena trditev ne bi mogla biti odobrena, je v skladu s pogoji iz člena 21(1) Uredbe (ES) št. 1924/2006 omejena v prid vložnika za pet let od datuma začetka veljavnosti te uredbe.
The scientific data and other information included in the application, which are claimed by the applicant as proprietary and without the submission of which the health claim could not have been authorised are restricted for use for the benefit of the applicant for a period of five years from the date of entry into force of this Regulation under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006.
Člen 3
The Annex to Regulation (EU) No 432/2012 is amended in accordance with the Annex to this Regulation.
Člen 4
This Regulation shall be binding in its entirety and directly applicable in all Member States.
V Bruslju, 31. marca 2015
Done at Brussels, 31 March 2015.
Za Komisijo
The President
UL L 404, 30.12.2006, str. 9.
OJ L 404, 30.12.2006, p. 9.
Uredba Komisije (EU) št. 432/2012 z dne 16. maja 2012 o seznamu dovoljenih zdravstvenih trditev na živilih, razen trditev, ki se nanašajo na zmanjšanje tveganja za nastanek bolezni ter na razvoj in zdravje otrok (UL L 136, 25.5.2012, str. 1).
Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (OJ L 136, 25.5.2012, p. 1).
Uredba Komisije (EU) št. 851/2013 z dne 3. septembra 2013 o odobritvi nekaterih zdravstvenih trditev na živilih, razen tistih, ki se nanašajo na zmanjšanje tveganja za nastanek bolezni ter na razvoj in zdravje otrok, in o spremembi Uredbe (EU) št. 432/2012 (UL L 235, 4.9.2013, str. 3).
ProDigest, 2012.
V Prilogi k Uredbi (EU) št. 432/2012 se vnos za kakavove flavanole nadomesti z naslednjim:
Pharmacokinetic study to assess the bioavailability of the cocoa flavanol epicatechin from different matrices.
Hranilo, snov, živilo ali kategorija živil
ProDigest Report nr.
Trditev
PD-2015009/C1-11.
Pogoji uporabe trditve
ANNEX
Pogoji in/ali omejitve uporabe živila in/ali dodatno pojasnilo ali opozorilo
In the Annex to Regulation (EU) No 432/2012, the entry for cocoa flavanols is replaced by the following:
Številka v strokovni reviji EFSA
Nutrient, substance, food or food category
Ustrezna številka vnosa na konsolidiranem seznamu, predloženem EFSA v oceno
Claim
„Kakavovi flavanoli
Conditions of use of the claim
Kakavovi flavanoli pomagajo ohranjati prožnost žil, kar pripomore k normalnemu pretoku krvi [1] [2].
Conditions and/or restrictions of use of the food and/or additional statement or warning
Potrošnike se obvesti, da se koristni učinek doseže z dnevnim vnosom 200 mg kakavovih flavanolov.
EFSA Journal number
Odobreno dne 24. septembra 2013 in omejeno na uporabo podjetja Barry Callebaut Belgium NV., Aalstersestraat 122, 9280 Lebbeke-Wieze, Belgija, za pet let.
Relevant entry number in the Consolidated List submitted to EFSA for its assessment
Odobreno dne 21. aprila 2015 in omejeno na uporabo podjetja Barry Callebaut Belgium NV, Aalstersestraat 122, 9280 Lebbeke-Wieze, Belgija, za pet let.“
Cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow [1] [2]
Trditev se lahko uporablja le za kapsule ali tablete z izvlečkom kakava z visoko vsebnostjo flavanolov, ki zagotavlja dnevni vnos vsaj 200 mg kakavovih flavanolov s stopnjo polimerizacije 1–10 [2].
Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 200 mg of cocoa flavanols.
Farmakokinetična študija za oceno biološke razpoložljivosti epikatekina kakavovih flavanolov v različnih matricah (Pharmacokinetic study to assess the bioavailability of the cocoa flavanol epicatechin from different matrices).
Commission Implementing Regulation (EU) 2015/540
Izvedbena uredba Komisije (EU) 2015/540
Commission Implementing Regulation (EU) 2015/543
Izvedbena uredba Komisije (EU) 2015/543
approving the active substance COS-OGA, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobritvi aktivne snovi COS-OGA v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet ter o spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular Article 22(1) in conjunction with Article 13(2) thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS [1] ter zlasti člena 22(1) v povezavi s členom 13(2) Uredbe,
In accordance with Article 7(1) of Regulation (EC) No 1107/2009, Belgium received on 28 June 2012 an application from FytoFend SA for the approval of the active substance COS-OGA.
V skladu s členom 7(1) Uredbe (ES) št. 1107/2009 je Belgija 28. junija 2012 prejela zahtevek podjetja FytoFend SA za odobritev aktivne snovi COS-OGA.
In accordance with Article 9(3) of that Regulation, Belgium, as rapporteur Member State, notified the Commission on 5 December 2012 of the admissibility of the application.
V skladu s členom 9(3) navedene uredbe je Belgija kot država članica poročevalka 5. decembra 2012 obvestila Komisijo o dopustnosti zahtevka.
On 19 December 2013 the rapporteur Member State submitted a draft assessment report to the Commission with a copy to the European Food Safety Authority (hereinafter ‘the Authority’), assessing whether that active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Država članica poročevalka je 19. decembra 2013 Komisiji predložila osnutek poročila o oceni, pri čemer je en izvod poslala Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija), v katerem je ocenila, ali je verjetno, da bo aktivna snov izpolnila merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009.
The Authority complied with Article 12(1) of Regulation (EC) No 1107/2009.
Agencija je izpolnila določbe člena 12(1) Uredbe (ES) št. 1107/2009.
In accordance with Article 12(3) of Regulation (EC) No 1107/2009, it requested that the applicant supply additional information to the Member States, the Commission and the Authority.
V skladu s členom 12(3) Uredbe (ES) št. 1107/2009 je zahtevala, da vlagatelj predloži dodatne informacije državam članicam, Komisiji in Agenciji.
The assessment of the additional information by the rapporteur Member State was submitted to the Authority in the format of an updated draft assessment report in September 2014.
Država članica poročevalka je septembra 2014 Agenciji predložila oceno dodatnih informacij v obliki posodobljenega osnutka poročila o oceni.
On 1 October 2014 the Authority communicated to the applicant, the Member States and the Commission its conclusion on whether the active substance COS-OGA can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 [2].
1. oktobra 2014 je Agencija vlagatelju, državam članicam in Komisiji posredovala svoj sklep o tem, ali se pričakuje, da bo aktivna snov COS-OGA izpolnila merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009 [2].
The Authority made its conclusion available to the public.
Agencija je svoj sklep dala na voljo javnosti.
On 11 December 2014 the Commission presented to the Standing Committee on Plants, Animals, Food and Feed the review report for COS-OGA and a draft Regulation providing that COS-OGA is approved.
11. decembra 2014 je Komisija Stalnemu odboru za rastline, živali, hrano in krmo predložila poročilo o pregledu COS-OGA in osnutek uredbe, ki določa, da se COS-OGA odobri.
It has been established with respect to one or more representative uses of at least one plant protection product containing the active substance, and in particular the uses which were examined and detailed in the review report, that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
V zvezi z eno ali več reprezentativnimi rabami vsaj enega fitofarmacevtskega sredstva, ki vsebuje aktivno snov, zlasti v zvezi z rabami, ki so bile proučene in podrobno navedene v poročilu o pregledu, je bilo ugotovljeno, da so merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009 izpolnjena.
Those approval criteria are therefore deemed to be satisfied.
Navedena merila za odobritev se torej štejejo za izpolnjena.
It is therefore appropriate to approve COS-OGA.
Zato je primerno, da se COS-OGA odobri.
The Commission further considers that COS-OGA is a low-risk active substance pursuant to Article 22 of Regulation (EC) No 1107/2009.
Komisija nadalje meni, da je COS-OGA aktivna snov z majhnim tveganjem v skladu s členom 22 Uredbe (ES) št. 1107/2009.
COS-OGA is not a substance of concern and fulfils the conditions set in point 5 of Annex II to Regulation (EC) No 1107/2009.
COS-OGA ni problematična snov in izpolnjuje pogoje iz točke 5 Priloge II k Uredbi (ES) št. 1107/2009.
COS-OGA consists of compounds naturally contained in plants and in some microorganisms and ubiquitous in the environment.
COS-OGA sestavljajo spojine, ki so naravno prisotne v rastlinah in nekaterih mikroorganizmih ter vseprisotne v okolju.
The additional exposure of humans, animals and the environment by the uses approved under Regulation (EC) No 1107/2009 is expected to be negligible compared to exposure expected through realistic natural situations.
Glede dodatne izpostavljenosti ljudi, živali in okolja zaradi rab, odobrenih na podlagi Uredbe (ES) št. 1107/2009, se pričakuje, da je zanemarljiva v primerjavi s pričakovano izpostavljenostjo v običajnih življenjskih situacijah.
It is therefore appropriate to approve COS-OGA as a low risk substance.
Zato je primerno odobriti COS-OGA kot snov z majhnim tveganjem.
In accordance with Article 13(4) of Regulation (EC) No 1107/2009, the Annex to Commission Implementing Regulation (EU) No 540/2011 [3] should be amended accordingly.
V skladu s členom 13(4) Uredbe (ES) št. 1107/2009 bi bilo treba ustrezno spremeniti Prilogo k Izvedbeni uredbi Komisije (EU) št. 540/2011 [3].
The active substance COS-OGA, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna snov COS-OGA, kot je opredeljena v Prilogi I, se odobri v skladu s pogoji iz navedene priloge.
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
Priloga k Izvedbeni uredbi (EU) št. 540/2011 se spremeni v skladu s Prilogo II k tej uredbi.
CAS No: not allocated
CAS: ni dodeljena
CIPAC No: 979
št.
Linear copolymer of α-1,4-D-galactopyranosyluronic acids and methylesterified galactopyranosyluronic acids (9 to 20 residues) with linear copolymer β-1,4-linked 2-amino-2-deoxy-D-glucopyranose and 2-acetamido-2-deoxy-D-glucopyranose (5 to 10 residues).
CIPAC: 979
OGA/COS ratio comprised between 1 and 1,6
Linear copolymer of α-1,4-D-galactopyranosyluronic acids and methylesterified galactopyranosyluronic acids (9 to 20 residues) with linear copolymer β-1,4-linked 2-amino-2-deoxy-D-glucopyranose and 2-acetamido-2-deoxy-D-glucopyranose (5 to 10 residues)
Degree of polymerisation of COS comprised between 5 and 10
razmerje OGA/COS med 1 in 1,6
Degree of polymerisation of OGA comprised between 9 and 20
stopnja polimerizacije COS med 5 in 10
Degree of methylation of OGA < 10 %
stopnja polimerizacije OGA med 9 in 20
Degree of acetylation of COS < 50 %
stopnja metilacije OGA < 10 %
22 April 2015
stopnja acetilacije COS < 50 %
22 April 2030
22. april 2015
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on COS-OGA, and in particular Appendices I and II thereof, shall be taken into account.
22. april 2030
Further details on identity and specification of active substance are provided in the review report.
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu COS-OGA ter zlasti dodatkov I in II k poročilu.
ANNEX II
Več podrobnosti o aktivni snovi in njenih lastnostih je v poročilu o pregledu.
In Part D of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added:
PRILOGA II
Linear copolymer of α-1,4-D-galactopyranosyluronic acids and methylesterified galactopyranosyluronic acids (9 to 20 residues) with linear copolymer β-1,4-linked 2-amino-2-deoxy-D-glucopyranose and 2-acetamido-2-deoxy-D-glucopyranose (5 to 10 residues).
Linear copolymer of α-1,4-D-galactopyranosyluronic acids and methylesterified galactopyranosyluronic acids (9 to 20 residues) with linear copolymer β-1,4-linked 2-amino-2-deoxy-D-glucopyranose and 2-acetamido-2-deoxy-D-glucopyranose (5 to 10 residues)
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on COS-OGA, and in particular Appendices I and II thereof, shall be taken into account.’
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu COS-OGA ter zlasti dodatkov I in II k poročilu.“
Commission Implementing Regulation (EU) 2015/544
Izvedbena uredba Komisije (EU) 2015/544
Council Implementing Regulation (EU) 2015/548
Izvedbena uredba Sveta (EU) 2015/548
implementing Regulation (EU) No 359/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Iran
o izvajanju Uredbe (EU) št. 359/2011 o omejevalnih ukrepih proti nekaterim osebam, subjektom in organom zaradi razmer v Iranu
Having regard to Council Regulation (EU) No 359/2011 of 12 April 2011 concerning restrictive measures against certain persons, entities and bodies in view of the situation in Iran [1], and in particular Article 12(1) thereof,
ob upoštevanju Uredbe Sveta (EU) št. 359/2011 z dne 12. aprila 2011 o omejevalnih ukrepih proti nekaterim osebam, subjektom in organom zaradi razmer v Iranu [1] ter zlasti člena 12(1) Uredbe,
On the basis of a review of Council Decision 2011/235/CFSP [2], the Council has decided that the restrictive measures therein should be renewed until 13 April 2016.
Svet je na podlagi pregleda Sklepa Sveta 2011/235/SZVP [2] sklenil, da bi bilo treba omejevalne ukrepe iz navedenega sklepa podaljšati do 13. aprila 2016.
The Council has also concluded that the entries concerning certain persons and one entity included in Annex I to Regulation (EU) No 359/2011 should be updated.
Svet je sklenil tudi, da bi bilo treba posodobiti vnose, ki zadevajo nekatere osebe in en subjekt iz Priloge I k Uredbi (EU) št. 359/2011.
Furthermore, there are no longer grounds for keeping two persons on the list of persons and entities subject to restrictive measures set out in Annex I to Regulation (EU) No 359/2011.
Poleg tega pri dveh osebah ni več razlogov, da bi bili še naprej na seznamu oseb in subjektov, za katere veljajo omejevalni ukrepi, iz Priloge I k Uredbi (EU) št. 359/2011.
In addition, one entry concerning a person already included in Annex I to Regulation (EU) No 359/2011should be deleted.
Prav tako bi bilo treba črtati en vnos, ki zadeva osebo, že vključeno v Prilogo I k Uredbi (EU) št. 359/2011.
Annex I to Regulation (EU) No 359/2011 should be amended accordingly,
Prilogo I k Uredbi (EU) št. 359/2011 bi bilo treba ustrezno spremeniti –
Annex I to Council Regulation (EU) No 359/2011 is amended as set out in the Annex to this Regulation.
Priloga I k Uredbi Sveta (EU) št. 359/2011 se spremeni, kot je določeno v Prilogi k tej uredbi.
The entries for the following persons shall be deleted from the list set out in Annex I to Council Regulation (EU) No 359/2011:
Vnosi za naslednje osebe se črtajo s seznama iz Priloge I k Uredbi Sveta (EU) št. 359/2011:
The entries for the following persons and entity as set out in in Annex I to Council Regulation (EU) No 359/2011 shall be replaced by the entries below:
Vnosi za naslednje osebe in subjekte iz Priloge I k Uredbi Sveta (EU) št. 359/2011 se nadomestijo z naslednjimi vnosi:
POB: Isfahan (Iran) — DOB:1963
Kraj rojstva: Isfahan (Iran) – Datum rojstva: 1963
As Deputy Chief of National Police from 2008, Radan was responsible for beatings, murder, and arbitrary arrests and detentions against protestors that were committed by the police forces.
Namestnik poveljnika obveščevalne enote IRGC.
POB: Tehran — DOB: 1963
Sojenja pod njegovim nadzorom so potekala po hitrem postopku in za zaprtimi vrati, brez spoštovanja temeljnih pravic obtožencev in ob zanašanju na priznanja, pridobljena pod pritiskom in z mučenjem.
Forces under his command participated in mass beatings, murders, detentions and tortures of peaceful protestors.
Član skupščine strokovnjakov in predstavnik vrhovnega vodje v („osrednji“) provinci Markazi.
Former Head of Mashhad Judiciary until September 2014.
Nekdanji iranski generalni tožilec (do septembra 2009) ter nekdanji minister za obveščevalne dejavnosti v času predsedovanja Mohameda Hatamija.
Trials under his supervision have been conducted summarily and inside closed sessions, without adherence to basic rights of the accused, and with reliance on confessions extracted under pressure and torture.
Odgovoren je tudi za zlorabe v centru za pridržanje Kahrizak.
As execution rulings were issued en masse, death sentences were issued without proper observance of fair hearing procedures.
Nekdanji sodnik v podružnici 26 revolucionarnega sodišča v Teheranu.
DORRI- NADJAFABADI Ghorban-Ali
Pristojen je bil za primere zapornikov, povezanih s krizo po volitvah, in redno grozil družinam zapornikov, da bi jih utišal.
POB: Najafabad (Iran) — DOB: 1945
Imel je ključno vlogo pri izdajanju odredb o pridržanju v centru za pridržanje Kahrizak.
Member of the Assembly of Experts and representative of the Supreme Leader in Markazi (‘Central’) Province.
Iranske oblasti so novembra 2014 uradno priznale njegovo vlogo pri smrti pripornikov.
As Prosecutor General of Iran, he ordered and supervised the show trials following the first post-election protests, where the accused were denied their rights, and an attorney.
Sodeloval je na sojenjih protestnikom.
He also carries responsibility for the Kahrizak abuses.
Sodniki so ga zaslišali v zvezi z nasiljem v centru za pridržanje Kahrizak.
HADDAD Hassan (alias Hassan ZAREH DEHNAVI)
Imel je ključno vlogo pri izdajanju odredb o pridržanju zapornikov v centru za pridržanje Kahrizak.
Former Judge, Tehran Revolutionary Court, branch 26.
Kraj rojstva: Yazd (Iran) – Datum rojstva: 1953
He was in charge of the detainee cases related to the post-election crises and regularly threatened families of detainees in order to silence them.
Njegov urad si je obenem za tarče izbiral in aretiral reformiste, aktiviste za človekove pravice in predstavnike medijev, kar je bil del vsesplošnega zatiranja politične opozicije.
He has been instrumental in issuing detention orders to the Kahrizak Detention Centre.
MOGHISSEH Mohammad (tudi NASSERIAN)
In November 2014, his role in the deaths of detainees was officially recognised by the Iranian authorities.
Sodnik in vodja podružnice 28 revolucionarnega sodišča v Teheranu.
Former Judge, Tehran Revolutionary Court.
Pristojen je za primere, povezane z obdobjem po volitvah.
He was questioned by the Judiciary about Kahrizak exactions.
Kraj rojstva: Ejiyeh – Datum rojstva: okrog leta 1956
POB: Yazd (Iran) — DOB: 1953
Nekdanji teheranski generalni tožilec (do avgusta 2009).
Prosecutor general of Tehran since August 2009.
Kot teheranski generalni tožilec je izdal splošno odredbo, na podlagi katere so pridržali več sto aktivistov, novinarjev in študentov.
Dolatabadi's office indicted a large number of protesters, including individuals who took part in the December 2009 Ashura Day protests.
Parlamentarni preiskovalci so januarja 2010 ugotovili, da je neposredno odgovoren za pridržanje treh zapornikov, ki so nato v priporu umrli.
He ordered the closure of Karroubi's office in September 2009 and the arrest of several reformist politicians, and he banned two reformist political parties in June 2010.
Po preiskavi, ki jo je sprožilo iransko sodstvo v zvezi z njegovo vlogo pri smrti treh moških, pridržanih po volitvah na njegov ukaz, je bil avgusta 2010 razrešen s položaja.
His office charged protesters with the charge of Muharebeh, or enmity against God, which carries a death sentence, and denied due process to those facing the death sentence.
Sodnik v podružnici 26 revolucionarnega sodišča v Teheranu.
His office also targeted and arrested reformists, human rights activists, and members of the media, as part of a broad crackdown on the political opposition.
Pristojen je za povolilne primere.
NASSERIAN)
Sodnik vrhovnega sodišča.
Judge, Head of Tehran Revolutionary Court, branch 28.
Nekdanji sodnik revolucionarnega sodišča v Mashadu.
He has dealt with post-election cases.
Sojenja, za katera je bil pristojen, so potekala po hitrem postopku in za zaprtimi vrati, brez spoštovanja temeljnih pravic obtožencev.
He issued long prison sentences during unfair trials for social, political activists and journalists and several death sentences for protesters and social and political activists.
Vodja pravosodnih organov v Teheranu.
POB: Ejiyeh -DOB: circa 1956
Nekdanji vodja iranske organizacije za zapore.
Prosecutor General of Iran since September 2009 and spokesman of the Judiciary, and former Intelligence minister during the 2009 elections.
Na tem položaju je bil vpleten v množično priprtje političnih protestnikov in prikrivanje zlorab v okviru zaporniškega sistema.
While he was Intelligence minister during the 2009 election, intelligence agents under his command were responsible for detention, torture and extraction of false confessions under pressure from hundreds of activists, journalists, dissidents, and reformist politicians.
Generalni direktor iranskega glavnega urada za boj proti drogam.
In addition, political figures were coerced into making false confessions under unbearable interrogations, which included torture, abuse, blackmail, and the threatening of family members.
Nekdanji poveljnik teheranske policije.
POB: Meybod, Yazd (Iran) — DOB: 1967
Pod njegovim vodstvom je bila policija odgovorna za izvensodno uporabo sile proti osumljencem med aretacijami in v priporu.